Total planned funding: $232,895,873
Allocations
Countries/Regions
Eswatini | $232,895,873 |
Organizational Types
Private Contractor | $59,744,782 |
University | $50,445,490 |
NGO | $47,988,615 |
Own Agency | $29,616,907 |
Unknown | $26,452,064 |
Host Country Government Agency | $9,773,308 |
FBO | $6,188,454 |
Multi-lateral Agency | $1,803,840 |
Other USG Agency | $712,813 |
Implementing Agency | $169,600 |
Program Areas
Care | $74,013,657 |
Treatment | $45,298,097 |
Prevention | $44,415,222 |
Governance and Systems | $30,435,355 |
Testing | $20,262,047 |
Management and Operations | $18,471,495 |
Budget Codes
HTXS: Treatment: Adult Treatment | $36,348,388 |
HBHC: Care: Adult Care and Support | $33,204,071 |
HKID: Care: Orphans and Vulnerable Children | $21,247,895 |
HVCT: Testing: HIV Testing and Counseling | $20,262,047 |
HVMS: Management and Operations | $18,471,495 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,347,218 |
HVTB: Care: TB/HIV | $13,436,629 |
OHSS: Health Systems Strengthening | $13,294,007 |
HVSI: Strategic Information | $11,361,922 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,250,987 |
HVOP: Sexual Prevention: Other Sexual Prevention | $9,104,150 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,725,867 |
PDCS: Care: Pediatric Care and Support | $6,125,062 |
HLAB: Laboratory Infrastructure | $5,779,426 |
HTXD: Treatment: ARV Drugs | $4,521,619 |
PDTX: Treatment: Pediatric Treatment | $4,428,090 |
HMBL: Biomedical Prevention: Blood Safety | $1,987,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$43,232,955
Countries/Regions
Pact, Inc.:
$27,841,998
Countries/Regions
Not Available:
$22,053,078
Countries/Regions
USG Aggregated Agencies:
$15,968,155
Countries/Regions